Mirum Pharmaceuticals, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: San Diego CA United States (2018)

Organization Overview

First Clinical Trial
2019
NCT03905330
First Marketed Drug
2021
maralixibat
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MIRUM | Mirum Pharmaceuticals, Inc. | MIRUM PHARMA INC